Ignite Creation Date:
2024-05-06 @ 2:12 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04246996
Status:
COMPLETED
Last Update Posted:
2022-11-08
First Post:
2020-01-27
Brief Title:
Gentamicin Intravesical Efficacy for Infection of Urinary Tract
Sponsor:
Kaiser Permanente
Organization:
Kaiser Permanente
Study Overview
Official Title:
Gentamicin Intravesical Efficacy for Infection of Urinary Tract
Status:
COMPLETED
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GIVEIT
Brief Summary:
Urinary tract infection UTI is a common problem after surgery for pelvic organ prolapse and stress urinary incontinence This prospective randomized single-masked subject two-parallel armed study aims to determine the effect of a single postoperative intravesical instillation of 80 mg of gentamicin sulfate in 50 mL of saline versus usual care on the proportion of women treated for UTI within 6 weeks following surgery for pelvic organ prolapse POP or stress urinary incontinence SUI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 12297 | OTHER | None | None |
| 191835 | OTHER | UC San Diego Health IRB | None |